KLRA analyst estimates

Kailera Therapeutics (KLRA) analyst ratings, the average price target and its range, and every firm's latest call.

• 0 firms rate KLRA: 0 buy, 0 hold, 0 sell.
• The average price target is $42.00 from None analysts, from $36.00 to $48.00.

Updated 2026-11-10 04:45 UTC